Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
11 |
|
2004 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
11 |
|
2003 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.100 |
None |
1.000 |
11 |
|
1988 |
2014 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
10 |
|
1998 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
10 |
|
2004 |
2019 |
Cardiac troponin T measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
19
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.050 |
None |
1.000 |
5 |
|
1988 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
anaphylaxis
|
phenotype |
Immune System Diseases
|
Disease or Syndrome
|
180
|
4
|
0.040 |
None |
1.000 |
4 |
|
2007 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2019 |
Hantavirus Infections
|
group |
Infections
|
Disease or Syndrome
|
108
|
10
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2017 |
Polycythemia Vera
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
291
|
38
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2018 |
Hermanski-Pudlak Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
70
|
59
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2017 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2018 |
Urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
168
|
11
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2017 |
Childhood Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2208
|
151
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |